238 related articles for article (PubMed ID: 12466264)
1. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
Marathe GK; Zimmerman GA; McIntyre TM
J Biol Chem; 2003 Feb; 278(6):3937-47. PubMed ID: 12466264
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase action of platelet-activating factor acetylhydrolase, but not paraoxonase-1, on long fatty acyl chain phospholipid hydroperoxides.
Kriska T; Marathe GK; Schmidt JC; McIntyre TM; Girotti AW
J Biol Chem; 2007 Jan; 282(1):100-8. PubMed ID: 17090529
[TBL] [Abstract][Full Text] [Related]
3. Hydrolysis of platelet-activating factor by human serum paraoxonase.
Rodrigo L; Mackness B; Durrington PN; Hernandez A; Mackness MI
Biochem J; 2001 Feb; 354(Pt 1):1-7. PubMed ID: 11171072
[TBL] [Abstract][Full Text] [Related]
4. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
[TBL] [Abstract][Full Text] [Related]
5. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis.
De Geest B; Stengel D; Landeloos M; Lox M; Le Gat L; Collen D; Holvoet P; Ninio E
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E68-75. PubMed ID: 11031226
[TBL] [Abstract][Full Text] [Related]
6. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.
Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Goudevenos JA; Chapman MJ; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):306-11. PubMed ID: 11834533
[TBL] [Abstract][Full Text] [Related]
8. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
Kakafika AI; Xenofontos S; Tsimihodimos V; Tambaki AP; Lourida ES; Kalaitzidis R; Cariolou MA; Elisaf M; Tselepis AD
J Lipid Res; 2003 Oct; 44(10):1919-26. PubMed ID: 12867538
[TBL] [Abstract][Full Text] [Related]
9. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
[TBL] [Abstract][Full Text] [Related]
10. Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging.
Milochevitch C; Khalil A
Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):241-6. PubMed ID: 11993715
[TBL] [Abstract][Full Text] [Related]
11. The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties.
Stafforini DM; Rollins EN; Prescott SM; McIntyre TM
J Biol Chem; 1993 Feb; 268(6):3857-65. PubMed ID: 8440681
[TBL] [Abstract][Full Text] [Related]
12. Lack of protection against oxidative modification of LDL by avian HDL.
Mackness B; Durrington PN; Mackness MI
Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
[TBL] [Abstract][Full Text] [Related]
13. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
Steinbrecher UP; Pritchard PH
J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
[TBL] [Abstract][Full Text] [Related]
15. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice.
Forte TM; Subbanagounder G; Berliner JA; Blanche PJ; Clermont AO; Jia Z; Oda MN; Krauss RM; Bielicki JK
J Lipid Res; 2002 Mar; 43(3):477-85. PubMed ID: 11893784
[TBL] [Abstract][Full Text] [Related]
16. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
[TBL] [Abstract][Full Text] [Related]
17. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
[TBL] [Abstract][Full Text] [Related]
18. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
Bacchetti T; Vignini A; Giulietti A; Nanetti L; Provinciali L; Luzzi S; Mazzanti L; Ferretti G
J Alzheimers Dis; 2015; 46(1):179-86. PubMed ID: 25720407
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite.
Connelly PW; Draganov D; Maguire GF
Free Radic Biol Med; 2005 Jan; 38(2):164-74. PubMed ID: 15607900
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
Van Lenten BJ; Hama SY; de Beer FC; Stafforini DM; McIntyre TM; Prescott SM; La Du BN; Fogelman AM; Navab M
J Clin Invest; 1995 Dec; 96(6):2758-67. PubMed ID: 8675645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
